Comparative study of therapeutic effects of Gabapentin versus plasebo on Restless legs syndrome in hemodialysis patientes

Not Applicable

• Conditions: RLS: Restless Legs syndrome.; Other specified extrapyramidal and movement disorders; G 25.8

• Registration Number: IRCT2014092319273N1
• Lead Sponsor: Vice-chancellor of Research and Technology of Ahvaz,Jundishapur University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 109

Inclusion Criteria

Inclusion critria:
at least 3 months of hemodialysis ;international severity scale more than 8

Exclusion criteria:
Pregnancy ;Under treatment with psychotropic agents ;presence of another neurologic disease ;Iron deficiency anemia.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of restless leg syndrome. Timepoint: At first and 4 weeks after first drug administration and4 weeks after second drug administration. Method of measurement: with international scale.

Secondary Outcome Measures

Name	Time	Method
Drug advers reaction. Timepoint: At first and 4 weeks after first drug administration and 4 weeks after second drug administration. Method of measurement: with question from patients.